Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):356–362. doi: 10.1097/QAI.0b013e31827f578a

Table 1.

Comparison of persons with complete retention in HIV care to those with ≥1 “out of care” year in HIV care, among 61,438 individuals with ≥1 HIV-lab in the NA-ACCORD, 2000–2008

Characteristic Retention in Care: Complete Retention in Care: Out ≥1 Time P-valuea
Total 46,078 (75) 15,360 (25) <0.001
Ageb (years) 42 (36, 50) 41 (35, 48) <0.001
Sex 0.52
 Male 38,478 (75) 12,792 (25)
 Female 7,600 (75) 2,568 (25)
Race/Ethnicity <0.001
 Non-Hispanic White 18,048 (77) 5,264 (23)
 Non-Hispanic Black 15,174 (70) 6,416 (30)
 Hispanic 4,635 (80) 1,179 (20)
 Other/Unkown 8,221 (77) 2,501 (23)
HIV Risk <0.001
 MSM 16,528 (81) 3,949 (19)
 IDU 7,584 (65) 4,171 (35)
 Hetero 9,116 (76) 2,890 (24)
 Other/Unknown 12,850 (75) 4,350 (25)
CD4+ Countb (cells/mm3) 319 (150, 515) 347 (178, 553) <0.001
HIV-1 RNAb (log10 copies/mL) 3.80 (2.32, 4.82) 3.79 (2.60, 4.71) 0.15
ARTb <0.001
 Naïve 14,548 (71) 5,844 (29)
 Experienced 31,530 (77) 9,516 (23)
Country <0.001
 US 39,799 (74) 13,962 (26)
 Canada 6,279 (82) 1,398 (18)
Maximum Time in Care (years) 2.31 (0.57, 5.29) 6.03 (3.75, 8.43) <0.001
a

χ2 for categorical, Kruskal-Wallis for continuous variables

b

At 1st year of data contribution

Numbers are “Number (%)” if categorical, “Median (Inter-Quartile Range)” if continuous

HIV-lab: CD4+ lymphocyte count or HIV-1 RNA viral load

MSM: sexual contact between men; IDU: injection drug use; Hetero: heterosexual contact; ART: antiretroviral therapy